Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Women in Ecuador have a particularly high rate of fever and shivering with sublingual misoprostol – but whether this is due to altitude,…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD) and anemia, targeting higher hemoglobin levels with an erythropoietic agent is not helpful and is very…
NEW YORK (Reuters Health) – Coronary artery stenting does not reduce long-term rates of myocardial infarction (MI) or mortality in patients with stress-positive stable coronary artery disease, German…
NEW YORK (Reuters Health) – For some infertile men with nonobstructive azoospermia (NOA), varicocele repair leads to motile sperm in the ejaculate and spontaneous pregnancy, according to a…
NEW YORK (Reuters Health) – Up to 20% of tests for estrogen and progesterone receptors in breast cancers are false negatives or false positives, according to a consensus…
NEW YORK (Reuters Health) – Amlodipine decreases central systolic blood pressure more effectively when combined with valsartan than with atenolol, French researchers reported online April 19th in Hypertension.…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…
NEW YORK (Reuters Health) – In patients with diabetic nephropathy, high doses of B vitamins accelerate kidney dysfunction and increase the rate of myocardial infarction (MI) and strokes,…
NEW YORK (Reuters Health) – Intensive insulin therapy, targeting a blood glucose level of 130 mg/dL, may improve the likelihood of survival for severely burned children, according to…
NEW YORK (Reuters Health) – Reperfusing the myocardium within 5 hours of an infarction makes a real survival difference, research from Denmark shows. The study, conducted in patients…
